Return to Statistics Toolbox

Dot Plot analysis for Study ST000196

Select one or more experimental factors for control and test groups. The members of each group should be DIFFERENT.
Control(s)Experimental factorTest(s)
Recovery:five week recovery | Gender:female | Treatment:Cefoperazone treated (3)
Recovery:five week recovery | Gender:male | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:four week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:na | Gender:female | Treatment:No antibiotics (6)
Recovery:na | Gender:male | Treatment:No antibiotics (6)
Recovery:no recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:female | Treatment:IP clindamycin (5)
Recovery:no recovery | Gender:female | Treatment:Kanamycin treated (6)
Recovery:no recovery | Gender:female | Treatment:Metronidazole treated (5)
Recovery:no recovery | Gender:female | Treatment:Vancomycin treated (6)
Recovery:no recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:no recovery | Gender:male | Treatment:IP clindamycin (6)
Recovery:no recovery | Gender:male | Treatment:Kanamycin treated (4)
Recovery:no recovery | Gender:male | Treatment:Metronidazole treated (6)
Recovery:no recovery | Gender:male | Treatment:Vancomycin treated (6)
Recovery:one week recovery | Gender:female | Treatment:Cefoperazone treated (7)
Recovery:one week recovery | Gender:male | Treatment:Cefoperazone treated (5)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated (4)
Recovery:six week recovery | Gender:female | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated (3)
Recovery:six week recovery | Gender:male | Treatment:Cefoperazone treated IP clindamycin (6)
Recovery:three week recovery | Gender:female | Treatment:Cefoperazone treated (5)
Recovery:three week recovery | Gender:male | Treatment:Cefoperazone treated (7)
Recovery:two week recovery | Gender:female | Treatment:Cefoperazone treated (6)
Recovery:two week recovery | Gender:male | Treatment:Cefoperazone treated (6)
x-axis labels ?: Show a single class:
P-value cutoff:    Fold-change cutoff:    Sample normalization:
Use:   Maximum # of individual metabolites to display:
Group by:   Maximum # of (most significant) metabolites per class to use in group calculation:
Analysis:Combine data for all analyses?:     

  logo